-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
In the first year of listing, join hands to develop new cooperation in the field of AIDS diagnosis and treatment
As far as the deployment of both parties in the field of HIV diagnosis and treatment is concerned, 2021 is a crucial "first year of listing"
As a cutting-edge innovative drug R&D company, Aidi Pharmaceuticals is focusing on drug R&D and commercialization in the HIV field
PerkinElmer is a world-renowned technology company with decades of accumulation in infection diagnosis and other fields
Join forces to implement the strategy of "integration of AIDS diagnosis and treatment"
According to the latest data released by the National Health Commission, as of the end of October 2021, 1.
Starting from the strategy of “meeting the urgent needs of domestic AIDS treatment”, Aidi Pharmaceuticals is committed to practicing the concept of “integration of HIV diagnosis and treatment” by building a Chinese->
Taking this strategic cooperation signing as a starting point, the two parties will carry out a series of multi-dimensional business cooperation for the Chinese market in the future, including marketing, clinical research cooperation, and charity activities cooperation
About Addison Pharmaceutical
Jiangsu Aidi Pharmaceutical Co.